We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$312M
AUM Growth
+$21.3M
Cap. Flow
+$9.21M
Cap. Flow %
2.95%
Top 10 Hldgs %
56.55%
Holding
35
New
5
Increased
15
Reduced
12
Closed
2

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$5.28M
2
ELV icon
Elevance Health
ELV
+$4.62M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.01M
4
AMGN icon
Amgen
AMGN
+$3.84M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.13M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$10.3M
2
PFE icon
Pfizer
PFE
+$6.02M
3
GILD icon
Gilead Sciences
GILD
+$5.93M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.38M
5
INCY icon
Incyte
INCY
+$2.68M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
26
Bio-Rad Laboratories Class A
BIO
$8.47B
$3.37M 1.08%
13,829
-3,000
-18% -$902K
BNTX icon
27
BioNTech
BNTX
$23B
$2.73M 0.88%
30,000
-10,000
-25% -$1.12M
ASND icon
28
Ascendis Pharma A/S
ASND
$16.6B
$2.65M 0.85%
+17,000
New +$2.43M
BIIB icon
29
Biogen
BIIB
$29.5B
$2.55M 0.82%
18,639
-10,361
-36% -$1.48M
LNTH icon
30
Lantheus
LNTH
$7.03B
$2.44M 0.78%
25,000
-712
-3% -$66.6K
ACLX
31
DELISTED
Arcellx
ACLX
$2.3M 0.74%
+35,000
New +$2.37M
SOLV icon
32
Solventum
SOLV
$13.9B
$2.28M 0.73%
+30,000
New +$2.23M
TGTX icon
33
TG Therapeutics
TGTX
$8.53B
$2.17M 0.69%
+55,000
New +$1.85M
LEGN icon
34
Legend Biotech
LEGN
$3.73B
– –
-48,495
Closed -$1.58M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2025 Portfolio in Review

As of Q1 2025, Sector Gamma AS held 35 positions worth $312M, up 7.3% from $291M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sector Gamma AS's Q1 2025 filing shows 5 new, 15 increased, 12 reduced and 2 closed positions. Its largest new stake was Tandem Diabetes Care: 180,523 shares worth $3.46M. The largest sale was Medtronic, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • Sector Gamma AS's largest Q1 2025 buy was Tandem Diabetes Care: 180,523 shares worth $3.46M.
  • Sector Gamma AS added most to Elevance Health in Q1 2025, an estimated $4.62M increase.
  • Sector Gamma AS's biggest Q1 2025 reduction was Medtronic, cutting an estimated $10.3M.
  • Sector Gamma AS fully exited Legend Biotech in Q1 2025, selling an estimated $1.58M.
  • Sector Gamma AS's ten largest holdings make up 57% of its $312M portfolio in Q1 2025.
  • Sector Gamma AS opened 5 new positions and closed 2 in Q1 2025.
  • Sector Gamma AS's portfolio value rose 7.3% quarter-over-quarter to $312M.

Based on Sector Gamma AS's 13F filing for Q1 2025, filed 13 May 2025.